Related Experiment Video
Updated: May 8, 2026

08:41
Processing of Human Cardiac Tissue Toward Extracellular Matrix Self-assembling Hydrogel for In Vitro and In Vivo Applications
Published on: December 4, 2017
Resilin-Based Hybrid Hydrogels for Cardiovascular Tissue Engineering.
Christopher L McGann1, Eric A Levenson, Kristi L Kiick
1Department of Materials Science and Engineering, University of Delaware, Newark, DE 19716, USA.
Macromolecules
|August 20, 2013
Summary
Engineered resilin-like polypeptides (RLPs) form hybrid hydrogels for cardiovascular tissue engineering. These biocompatible materials support cell viability and tissue integration.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Protein Engineering
Background:
- Natural resilin exhibits exceptional elastomeric properties, inspiring biomaterial development.
- Resilin-like polypeptides (RLPs) are engineered proteins mimicking natural resilin's elasticity.
- Cardiovascular tissue engineering requires advanced biomaterials with specific mechanical and biological cues.
Purpose of the Study:
- To engineer RLP-PEG hybrid hydrogels for cardiovascular tissue engineering applications.
- To evaluate the mechanical properties and biocompatibility of the developed hydrogels.
- To assess the ability of the hydrogels to support human aortic adventitial fibroblast viability and morphology.
Main Methods:
- Resilin-like polypeptides (RLPs) incorporating biofunctional domains were synthesized.
- RLPs were cross-linked with multi-arm star PEG-vinyl sulfones to form hybrid hydrogels via Michael-type addition.
- Oscillatory rheology was used to characterize hydrogel mechanical properties.
- Confocal microscopy assessed human aortic adventitial fibroblast viability and morphology within the 3D hydrogel matrices.
Main Results:
- RLP-PEG hybrid hydrogels demonstrated useful mechanical properties via oscillatory rheology.
- Successful encapsulation of human aortic adventitial fibroblasts within the 3D matrices was confirmed.
- Fibroblasts exhibited a spread morphology after 7 days of culture, indicating good biocompatibility.
Conclusions:
- Engineered RLP-PEG hybrid hydrogels show promise as biomaterials for cardiovascular tissue engineering.
- The hydrogels provide a supportive microenvironment for fibroblast survival and function.
- Further development could lead to advanced regenerative therapies for cardiovascular applications.

